Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concurrent Cisplatin/Docetaxel/RT + Consolidation Docetaxel in Stage IIIB NSCLC
NCT00014196Phase 2Terminated
- Sponsor
- SWOG Cancer Research Network
- Start
- Mar 2001
- Primary completion
- Mar 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel in non-small cell lung cancer (NSCLC), sponsored by SWOG Cancer Research Network. Started Mar 2001; status: terminated.
02
Drugs
docetaxel
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00014196.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00014196.